Richardson, P. G., Siegel, D., Baz, R., Kelley, S. L., Munshi, N. C., Laubach, J., . . . Anderson, K. C. (2013). Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib. American Society of Hematology.
শিকাগো স্টাইলে সাইটেশনRichardson, Paul G., et al. Phase 1 Study of Pomalidomide MTD, Safety, and Efficacy in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib. American Society of Hematology, 2013.
এমএলএ সাইটেশনRichardson, Paul G., et al. Phase 1 Study of Pomalidomide MTD, Safety, and Efficacy in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib. American Society of Hematology, 2013.